Search

Your search keyword '"F L, Meyskens"' showing total 107 results

Search Constraints

Start Over You searched for: Author "F L, Meyskens" Remove constraint Author: "F L, Meyskens"
107 results on '"F L, Meyskens"'

Search Results

3. Re: Cancer Chemoprevention: Progress and Promise RESPONSE

4. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia

5. Redox regulation in human melanocytes and melanoma

6. Development of difluoromethyl-ornithine and Bowman-Birk inhibitor as chemopreventive agents by assessment of relevant biomarker modulation: some lessons learned

7. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial

9. Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial

11. Cancer population genetics and tumour prevention: an unfulfilled paradigm

12. Criteria for implementation of large and multiagent clinical chemoprevention trials

13. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia

14. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor

15. Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress

16. Development of difluoromethylornithine (DFMO) as a chemoprevention agent

17. Chemoprevention of human cancer: a reasonable strategy?

18. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study

19. Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial

20. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group

21. Levels of proteolytic activities as intermediate marker endpoints in oral carcinogenesis

22. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study

23. Evaluation and treatment of the patient with early melanoma

24. Differences in basic fibroblast growth factor RNA and protein levels in human primary melanocytes and metastatic melanoma cells

25. Chemoprevention of breast cancer

26. Strategies for prevention of cancer in humans

27. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine

28. Biomarker intermediate endpoints and cancer prevention

29. Chemoprevention of cancer

30. Effect of single dose ionizing radiation on the cellular proliferation and apparent radiosensitivity of melanoma

31. Development of a contingency recruitment plan for a phase III chemoprevention trial of cervical dysplasia

34. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.

40. The human thymus. I. Partial characterization of nonlymphoid cells

42. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations

43. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)

44. Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients

45. Pharmacokinetics of 13-cis-retinoic acid in patients with advanced cancer

48. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma

49. Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease

Catalog

Books, media, physical & digital resources